Akiko Saito-Moriya
Nagoya, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 21 publications
Outcome of chemotherapy dose reduction in overweight Japanese children with acute lymphoblastic leukemia.
Journal: International journal of hematology
Published: June 01, 2025
Outcomes of children with T-cell acute lymphoblastic leukemia treated with the JACLS T-02 protocol.
Journal: International journal of hematology
Published: December 26, 2024
Differential impact of asparaginase discontinuation on outcomes of children with T-cell acute lymphoblastic leukemia and T-cell lymphoblastic lymphoma.
Journal: Cancer medicine
Published: December 09, 2023
High-dose cytarabine induction therapy and flow cytometric measurable residual disease monitoring for children with acute myeloid leukemia.
Journal: Leukemia
Published: July 28, 2023
Outcome of hematopoietic stem cell transplantation in pediatric patients with acute lymphoblastic leukemia not in remission enrolled in JACLS ALL-02.
Journal: International journal of hematology
Published: November 28, 2022
JACLS ALL-02 SR protocol reduced-intensity chemotherapy produces excellent outcomes in patients with low-risk childhood acute lymphoblastic leukemia.
Journal: International journal of hematology
Published: December 27, 2021
The incidence of symptomatic osteonecrosis is similar between Japanese children and children in Western countries with acute lymphoblastic leukaemia treated with a Berlin-Frankfurt-Münster (BFM)95-based protocol.
Journal: British journal of haematology
Published: September 29, 2021
Characteristics of genetic alterations of peripheral T-cell lymphoma in childhood including identification of novel fusion genes: the Japan Children's Cancer Group (JCCG).
Journal: British journal of haematology
Published: February 25, 2021
Negative CD19 expression is associated with inferior relapse-free survival in children with RUNX1-RUNX1T1-positive acute myeloid leukaemia: results from the Japanese Paediatric Leukaemia/Lymphoma Study Group AML-05 study.
Journal: British journal of haematology
Published: April 05, 2019
Last Updated: 09/26/2026